Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rang în acțiuni #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Preț acțiune
$137.21
Capitalizare de piață
$170.34B
Schimbare (1 zi)
-2.76%
Schimbare (1 an)
28.14%
Țară
US
Tranzacționează Gilead Sciences, Inc. (GILD)

Categorie

Raport P/S pentru Gilead Sciences, Inc. (GILD)
Raport P/S la data de March 2026 TTM: 6.11
Conform celor mai recente rapoarte financiare și prețului acțiunilor Gilead Sciences, Inc., raportul P/S actual (TTM) este 6.11. La sfârșitul anului 2024, compania avea un P/S de 4.01.
Istoricul raportului P/S pentru Gilead Sciences, Inc. din 2000 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 6.11 17.79%
2025 5.19 29.46%
2024 4.01 7.44%
2023 3.73 -5.59%
2022 3.95 18.24%
2021 3.34 12.60%
2020 2.97 -19.31%
2019 3.68 0.19%
2018 3.67 2.31%
2017 3.59 13.67%
2016 3.16 -30.48%
2015 4.54 -21.25%
2014 5.76 -43.76%
2013 10.25 78.72%
2012 5.73 51.64%
2011 3.78 -3.10%
2010 3.90 -30.11%
2009 5.58 -36.72%
2008 8.82 -12.66%
2007 10.10 2.59%
2006 9.85 -16.34%
2005 11.77 3.14%
2004 11.41 -15.54%
2003 13.51 -5.12%
2002 14.24 -46.77%
2001 26.76 38.69%
2000 19.29 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
14.26 133.21%
US
4.96 -18.85%
GB
6.18 1.07%
US
6.35 3.89%
US
5.18 -15.33%
CH